Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

RNA Splicing01:32

RNA Splicing

60.6K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

25.1K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
25.1K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.1K
No description available
5.1K
Gene Therapy00:59

Gene Therapy

27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Chromatin Structure and RNA Splicing02:41

Chromatin Structure and RNA Splicing

3.4K
No description available
3.4K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

735
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
735

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids.

Skeletal muscle·2026
Same author

Creatine/Creatinine Ratio and Myostatin as Biomarkers to Monitor Muscle Function in Duchenne Muscular Dystrophy Patients.

Journal of cachexia, sarcopenia and muscle·2026
Same author

Quantitative tandem mass tag-based serum proteomics for longitudinal biomarker monitoring in Duchenne muscular dystrophy.

Clinical proteomics·2026
Same author

MDBiomarkers: A queryable biomarkers database integrating multiple serum and tissue datasets for Duchenne muscular dystrophy.

Journal of neuromuscular diseases·2026
Same author

Guidance on communication and informed consent with patients and their families for experimental individualized treatments.

American journal of human genetics·2026
Same author

Paying for precision: funding approaches for N-of-1 trials of individualized gene targeted therapies.

Orphanet journal of rare diseases·2026

関連する実験動画

Updated: Jan 31, 2026

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.8K

人間の病気に対するスプライス調節療法.

Pietro Spitali1, Annemieke Aartsma-Rus

  • 1Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Cell
|March 20, 2012
PubMed
まとめ

遺伝子発現を変化させるプロセスであるスプライシングの調節不良は,多くの疾患を引き起こす. スプライシングの誤りを修正する治療戦略が生まれ,遺伝的および既得疾患に対する新しい治療の可能性を提示しています.

科学分野:

  • 分子生物学は分子生物学である.
  • 遺伝学 遺伝学とは
  • 治療薬として用いられる.

背景:

  • スプライシングと代替スプライシングは,重要な遺伝子発現プロセスです.
  • これらのプロセスの不調は,多くの遺伝的および既得性疾患に関与しています.
  • ターゲティングスプライシングは,有望な治療法を提供している.

研究 の 目的:

  • スプライシングを調節するための最近の治療戦略の概要を述べる.
  • 臨床および臨床前での成功を強調する.
  • スプライシングをターゲットに,有益なタンパク質を生成し,有害なタンパク質を除去するためのアプローチについて議論する.

主な方法:

  • スプライシング・モジュレーション療法に関する最近の文献のレビュー.
  • 臨床および臨床前データの分析.
  • 治療戦略の分類は,その作用メカニズムに基づいて行われます.

主要な成果:

  • いくつかの戦略は,治療的にスプライシングを効果的に調節します.
  • アプローチには,開いた読書フレームを復元し,代替スプライシングに影響を与え,エクソンインクルージョンを誘導するなどがあります.

さらに関連する動画

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.4K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K

関連する実験動画

Last Updated: Jan 31, 2026

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
08:47

Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes

Published on: December 16, 2022

2.8K
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.4K
Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

13.4K
  • これらの方法は,機能的なタンパク質を生産するか,有害なタンパク質を排除することを目的としています.
  • 結論:

    • 治療用のスプライシング・モジュレーションは,急速に進歩している分野です.
    • 成功した戦略は,臨床および臨床前での設定に翻訳されています.
    • ターゲティングスプライシングは,幅広い病気の治療に重要な可能性を秘めています.